IBEX Technologies Inc. IBEX Technologies Inc.

IBEX Technologies Inc.

IBT

Classificação em ações #28694
Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc.... Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.
Preço da ação
$1.05
Última sincronização: 2024-04-11
Valor de mercado
$23.31M
Variação (1 dia)
-0.01%
Variação (1 ano)
5.21%
País
CA
Negociar IBEX Technologies Inc. (IBT)

Categoria

Healthcare
Histórico de preços das ações de IBEX Technologies Inc. (IBT)
Preço de fecho mais alto: $1.00 em 2024-04-01

Preço de fecho mais baixo: $0.18 em 2018-08-01
Histórico de preços das ações da IBEX Technologies Inc. de 2018 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 39.28%
2023 66.64%
2022 60.33%
2021 33.14%
2020 119.45%
2019 -31.94%
2018 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $523.31 22.71%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $237.47 784.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $137.83 -3.78%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $874.99 7.47%
NL
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $287.83 1.13%
BE